CNS Pharmaceuticals, Inc.

CNSP · Nasdaq · SIC 2834: Pharmaceutical Preparations
168
SEC Filings

Business Summary

PART I . Overview CNS Pharmaceuticals, Inc. (CNS, the Company, we, us, or our) is a biotechnology company focused on developing innovative therapies for serious diseases in neurology and oncology. Together, these therapeutic areas represent hundreds of billions of dollars in annual global pharmaceutical spending, encompass some of the most prevalent and difficult to treat diseases affecting humanity, and are characterized by significant unmet medical need. Significant progress has been made in t...

Next Earnings

Q2 FY2026 — expected 2026-07-16

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionCNSPdiscussed_in_filing Cybersecurity
topic_mentionCNSPdiscussed_in_filing Trusted Computing
topic_mentionCNSPdiscussed_in_filing Blockchain & Crypto
topic_mentionCNSPdiscussed_in_filing Supply Chain
topic_mentionCNSPdiscussed_in_filing Regulation
topic_mentionCNSPdiscussed_in_filing Healthcare & Bio
topic_mentionCNSPdiscussed_in_filing Platform & Ecosystem
topic_mentionCNSPdiscussed_in_filing Sovereign & Government
topic_mentionCNSPdiscussed_in_filing Cybersecurity
topic_mentionCNSPdiscussed_in_filing Trusted Computing
topic_mentionCNSPdiscussed_in_filing Blockchain & Crypto
topic_mentionCNSPdiscussed_in_filing Supply Chain
topic_mentionCNSPdiscussed_in_filing Regulation
topic_mentionCNSPdiscussed_in_filing Healthcare & Bio
topic_mentionCNSPdiscussed_in_filing Platform & Ecosystem
topic_mentionCNSPdiscussed_in_filing Sovereign & Government
topic_mentionCNSPdiscussed_in_filing Cybersecurity
topic_mentionCNSPdiscussed_in_filing Trusted Computing
topic_mentionCNSPdiscussed_in_filing Blockchain & Crypto
topic_mentionCNSPdiscussed_in_filing Supply Chain

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-312025-12-310001683168-26-002550EDGAR43K words
2025-03-312024-12-310001683168-25-002139EDGAR
2024-04-012023-12-310001683168-24-002032EDGAR
2023-03-312022-12-310001683168-23-002086EDGAR
2022-03-032021-12-310001683168-22-001401EDGAR
2021-02-122020-12-310001683168-21-000533EDGAR
2020-03-122019-12-310001683168-20-000781EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-142025-09-300001683168-25-008466EDGAR14K words
2025-08-142025-06-300001683168-25-006162EDGAR
2025-05-152025-03-310001683168-25-003733EDGAR
2024-11-142024-09-300001683168-24-008125EDGAR
2024-08-142024-06-300001683168-24-005711EDGAR
2024-05-152024-03-310001683168-24-003531EDGAR
2023-11-142023-09-300001683168-23-008144EDGAR
2023-08-142023-06-300001683168-23-005609EDGAR
2023-05-152023-03-310001683168-23-003311EDGAR
2022-11-102022-09-300001683168-22-007532EDGAR
2022-08-122022-06-300001683168-22-005637EDGAR
2022-05-132022-03-310001683168-22-003588EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-110001683168-26-001664EDGAR1K words
2026-03-020001683168-26-001413EDGAR
2026-02-170001683168-26-001066EDGAR
2025-12-170001683168-25-009208EDGAR
2025-11-210001683168-25-008624EDGAR
2025-07-220001683168-25-005284EDGAR
2025-07-150001683168-25-005129EDGAR
2025-05-150001683168-25-003575EDGAR
2025-04-090001683168-25-002373EDGAR
2025-03-310001683168-25-002140EDGAR

168 total filings indexed. 139 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001729427
TickerCNSP
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedNV

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: a14027ab1f108461b59a89ef2d0b46f17635be49224776a39768bbcb0c86da35
parent: 0552ccd0c74e5ee6831ee0d892a975e1699df3610a7e76fdb0c9f12e74c99752
content hash: de6a1cfea68d1e8544a4ccc1fc282ff1657560559e089e84e06d6e6a998eed9d
signed: 2026-04-13T04:44:24.949Z
sources: 19 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf